Literature DB >> 2305087

Arteriogenic impotence: findings in 195 impotent men examined with selective internal pudendal angiography. Young Investigator's Award.

M P Rosen1, A J Greenfield, T G Walker, P Grant, J K Guben, J Dubrow, M A Bettmann, I Goldstein.   

Abstract

Selective internal pudendal angiography was performed in 195 men (average age, 35.4 years +/- 10.3) who were suspected of having arteriogenic impotence. In the majority of patients, disease was localized to the cavernosal arteries. A previous series that involved older patients had demonstrated significant disease in the hypogastric and internal pudendal arteries. When controlled for trauma, the data revealed no significant difference (X2 test, P greater than .10) in the distribution of hemodynamically significant penile arterial disease. However, in patients who had sustained major pelvic trauma, the common penile artery was frequently hemodynamically compromised. There is a great deal of variation in the origin of the internal pudendal artery. An accessory pudendal artery was demonstrated in 7% of the patients. If a selective internal pudendal artery injection fails to demonstrate the penile arterial anatomy, a less selective injection should be performed. Bilateral injections should always be performed, as unilateral arterial disease was present in 15% of the patients.

Entities:  

Mesh:

Year:  1990        PMID: 2305087     DOI: 10.1148/radiology.174.3.174-3-1043

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  Physiology of penile erection and pathophysiology of erectile dysfunction.

Authors:  Robert C Dean; Tom F Lue
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

2.  Transcatheter embolization of a ruptured internal pudendal artery pseudoaneurysm in a patient with neurofibromatosis type 1.

Authors:  Chang-Wei Zhang; Zhi-Gang Yang; Xiao-Dong Xie; Chao-Hua Wang; Chao You; Wei Li
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

3.  Endovascular therapy for vasculogenic erectile dysfunction.

Authors:  Jason H Rogers; Krishna J Rocha-Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

4.  Identification and preservation of accessory pudendal vessels during robot-assisted laparoscopic radical retropubic prostatectomy.

Authors:  Samuel P Sterrett; Timo Laurila; Gaurav Bandi; David F Jarrard
Journal:  J Robot Surg       Date:  2008-02-27

Review 5.  Current state of endovascular treatment for vasculogenic erectile dysfunction.

Authors:  Femi Philip; Mehdi H Shishehbor
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

6.  The neurovascular and muscular anomalies of the gluteal region: an atypical pudendal nerve.

Authors:  Y Kirici; F Yazar; H Ozan
Journal:  Surg Radiol Anat       Date:  1999       Impact factor: 1.246

7.  What is the best predictor of postoperative erectile function in patients who will undergo coronary artery bypass surgery?

Authors:  Fatih Hizli; Burak Işler; Zeki Güneş; M Ali Ozatik; Ferhat Berkmen
Journal:  Int Urol Nephrol       Date:  2007-03-02       Impact factor: 2.370

8.  The incidence and anatomy of accessory pudendal arteries as depicted on multidetector-row CT angiography: clinical implications of preoperative evaluation for laparoscopic and robot-assisted radical prostatectomy.

Authors:  Beom Jin Park; Deuk Jae Sung; Min Ju Kim; Sung Bum Cho; Yun Hwan Kim; Kyoo Byung Chung; Seok Ho Kang; Jun Cheon
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

Review 9.  Does the CaverMap device help preserve potency?

Authors:  H L Kim; D A Mhoon; C B Brendler
Journal:  Curr Urol Rep       Date:  2001-06       Impact factor: 3.092

10.  Probing penile hemodynamics by using photoplethysmography as objective indicators for male erection quality and sexual function.

Authors:  Yuan-Hung Pong; Yi-Kai Chang; Ching-En Hsu; Po-Cheng Chen; Yu-Chuan Lu; Vincent F S Tsai; Hong-Chiang Chang; Men-Tzung Lo; Chen Lin
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.